Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Frédéric Montels"'
Autor:
Pierre-Jean Lamy, Diego Tosi, Florence Castan, Sylvie Roques, Frédéric Montels, Benoit Leizour, Fabien Nielloud, Xavier Rebillard, Caroline Bascoul-Mollevi
Publikováno v:
Annales de biologie clinique. 71:537-544
The analytical and clinical validation of new biomarkers for the early detection of prostate is necessary. (-2)proPSA, total PSA and free PSA values are used to calculate a standardized PHI index linked to a higher probability of a positive biopsy in
Publikováno v:
Annales de biologie clinique. 68:325-329
Human epididymis protein 4 (HE4) is a novel marker for ovarian cancer. HE4 exhibits a high sensitivity to detect ovarian cancer and can be used with CA125 as a predictor of malignancy. Additional uses of HE4 are as an aid of monitoring response to th
Autor:
Cécile Montélion, Frédéric Bibeau, Frédéric Montels, Pierre-Jean Lamy, Nicolas Lozano, Patricia Audran, Anne-Claire Laberenne, Sylvie Roques, Florence Castan
Publikováno v:
Journal of Molecular Diagnostics
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2015, 17 (4), pp.366-373. ⟨10.1016/j.jmoldx.2015.02.004⟩
Journal of Molecular Diagnostics, American Society for Investigative Pathology (ASIP), 2015, 17 (4), pp.366-373. ⟨10.1016/j.jmoldx.2015.02.004⟩
International audience; The detection of the BRAF V600E mutation in melanoma samples is used to select patients who should respond to BRAF inhibitors. Different techniques are routinely used to determine BRAF status in clinical samples. However, low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7da54b4e14744a71682455c84bca0369
https://hal.umontpellier.fr/hal-02287121
https://hal.umontpellier.fr/hal-02287121
Autor:
Pierre-Emmanuel Colombo, Pierre-Jean Lamy, Stéphane Pouderoux, Frédéric Bibeau, William Jacot, Gilles Romieu, Simon Thezenas, Frédéric Montels, Haïdar Saadoun, Marian Gutowski
Publikováno v:
Future Oncology
Future Oncology, Future Medicine, 2014, 10, pp.195--209. ⟨10.2217/fon.13.177⟩
Future Oncology, Future Medicine, 2014, 10, pp.195--209. ⟨10.2217/fon.13.177⟩
ABSTRACT Aims: Following the introduction of new adjuvant therapies we wanted to reappraise the prognostic and predictive value of uPA/PAI-1 in early breast cancer. Patients & methods: This monocentric retrospective study included 652 patients who ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::917c1073a68b1ad5c88fa1c213620ddf
https://hal.umontpellier.fr/hal-02181364
https://hal.umontpellier.fr/hal-02181364
Autor:
Anna, Durigova, Pierre-Jean, Lamy, Simon, Thezenas, Stephane, Pouderoux, Frédéric, Montels, Gilles, Romieu, Marian, Gutowski, William, Jacot
Publikováno v:
Clinical chemistry and laboratory medicine. 51(9)
Anemia, a frequent and deleterious condition in patients with cancer, is mainly caused by chemotherapy toxicity, iron deficiency, or inflammation. We evaluated the baseline iron metabolism biomarkers and their association with anemia occurrence durin
Autor:
Marian Gutowski, Simon Thezenas, Anna Durigova, Pierre-Jean Lamy, William Jacot, Stéphane Pouderoux, Frédéric Montels, Gilles Romieu
Publikováno v:
Clinical Chemistry and Laboratory Medicine. 51
Background: Anemia, a frequent and deleterious condi tion in patients with cancer, is mainly caused by chemo therapy toxicity, iron deficiency, or inflammation. We evaluated the baseline iron metabolism biomarkers and their association with anemi
Autor:
Pierre-Jean Lamy, Sylvie Roques, Frédéric Montels, William Jacot, Stéphane Pouderoux, Anna Durigova
Publikováno v:
Annales de biologie clinique. 70(4)
Iron plays a fundamental role in biology and its concentration in living organisms is regulated very precisely. Many molecules of storage and transportation are used to maintain the intracellular homeostasis. Cancer cells have alterations in this bal
Publikováno v:
Annales de biologie clinique. 68(3)
Human epididymis protein 4 (HE4) is a novel marker for ovarian cancer. HE4 exhibits a high sensitivity to detect ovarian cancer and can be used with CA125 as a predictor of malignancy. Additional uses of HE4 are as an aid of monitoring response to th
Autor:
David Azria, Xavier Rebillard, D. Ayuso, Anne-Claire Laberenne, Sylvie Roques, Vincent Abd El Fattah, A. Faix, Samer Abdel-Hamid, Bruno Segui, Benoit Leizour, Pierre-Jean Lamy, Florence Castan, Frédéric Montels
Publikováno v:
Journal of Clinical Oncology. 32:5055-5055
5055 Background: The Prostate Health Index (PHI) and the Prostate CAncer gene 3 (PCA3) have shown to have predictive values for early detection of PCa. The aim of this prospective observational stu...